GlaxoSmithKline | GSK - Ebitda

Биржевая цена
1,941.00
Изменение за день
23.00 1.20%
Ежемесячно
-5.96%
Ежегодный
32.67%
Q2 прогноз
1,986.06




Ebitda Изменить Дата
AbbVie USD 5.37B 1.85B 2025-12
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amgen USD 5.14B 775M 2025-12
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 1.97B 457M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Glaxosmithkline GBP 4.75B 1.52B 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.3B 530M 2026-03
Novo Nordisk DKK 37.3B 5.86B 2025-12
Orion EUR 130.4M 212.6M 2026-03
Pfizer USD 6.08B 351M 2025-09
Philips EUR 738M 9M 2025-09
Recordati EUR 247.15M 421K 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12